Telmisartan市場：依成分、適應症、劑型、通路和地區分類

2025 年全球Telmisartan市場規模估計為 43.6 億美元，預計到 2032 年將達到 57.1 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 3.9%。

數字。 2025 年Telmisartan各地區市場佔有率（%）

Telmisartan為血管收縮素素II受體拮抗劑，主要用於治療高血壓、糖尿病腎臟病。該藥物透過選擇性抑制血管收縮素II 與血管平滑肌和腎上腺中的 AT1 受體結合發揮作用。Telmisartan可透過抑制血管收縮素II 的血管收縮和醛固酮分泌作用來降低血壓。Telmisartan是一種口服藥物，以多種商品名出售，其安全性已通過長期臨床試驗得到證實。人們對心血管健康的認知不斷提高以及高血壓盛行率的上升可能會推動全球Telmisartan市場的成長。

市場動態

全球Telmisartan市場的成長受到人口快速老化、全球高血壓盛行率上升、肥胖導致久坐生活方式增加以及新興國家醫療保健支出增加等因素的推動。然而，學名藥藥的出現以及主要品牌專利到期可能會給市場相關人員帶來挑戰。持續研究擴大Telmisartan的治療用途，並進行臨床試驗以評估其在治療高血壓以外的疾病方面的有效性，這可能會在不久的將來為相關人員提供機會。與開發中國家的當地分銷網路合作​​也提供了一個利用未滿足需求的有吸引力的途徑。

研究的主要特點

• 本報告對全球Telmisartan市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球Telmisartan市場的主要企業概況。
• 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球Telmisartan市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員將透過全球Telmisartan市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

4. 全球Telmisartan市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球Telmisartan市場（按配方分類）（十億美元）

• 介紹
• 單身的
• 組合

第 6 章。 2020 年至 2032 年Telmisartan全球市場（按適應症分類）（十億美元）

• 介紹
• 高血壓
• 腎臟病
• 肝腎症候群
• 心臟麻痹
• 中風

第 7 章。 2020-2032 年全球Telmisartan市場（以劑型分類）（十億美元）

• 介紹
• 錠劑
• 膠囊
• 注射
• 口服懸浮液

8. 2020-2032 年全球Telmisartan市場按分銷管道分類（十億美元）

• 介紹
• 醫院藥房
• 零售藥局
• 網路藥局

9. 2020 年至 2032 年全球Telmisartan市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第10章 競爭格局

• 公司簡介
  • Boehringer Ingelheim GmbH
  • Glenmark Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Mylan NV
  • Cipla Ltd.
  • Abbott Laboratories
  • Cadila Healthcare Ltd
  • Torrent Pharmaceuticals Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi SA
  • Bayer AG
  • AstraZeneca PLC
  • Daiichi Sankyo Company, Limited
  • Macleods Pharmaceuticals Ltd.

第 11 章 分析師建議

• 興衰
• 一致的機會地圖

第 12 章參考文獻與調查方法

• 參考
• 調查方法

Global Telmisartan Market is estimated to be valued at USD 4.36 Bn in 2025 and is expected to reach USD 5.71 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.9% from 2025 to 2032.

Figure. Telmisartan Market Share (%), By Region 2025

Telmisartan is an angiotensin II receptor antagonist that is used primarily in the treatment of hypertension and diabetic nephropathy. It works by selectively blocking the binding of angiotensin II to the AT1 receptors present in vascular smooth muscle and the adrenal glands. By blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II, telmisartan helps lower blood pressure. It is available under various brand names as an oral medication and has a well-established safety profile supported by long-term clinical trials. Growing awareness about cardiovascular health and increasing prevalence of hypertension can drive the global telmisartan market growth.

Market Dynamics:

Global telmisartan market growth is driven by factors such as rapidly aging population, rising prevalence of hypertension worldwide, increasing adoption of sedentary lifestyle resulting in obesity, and growing healthcare expenditure in emerging nations. However, availability of generic substitutes and patent expiration of major brands can pose challenges for market players. Continuous research on expanding therapeutic applications of telmisartan and ongoing clinical trials evaluating its efficacy in treatment of conditions beyond hypertension can offer opportunities for stakeholders in the near future. Partnerships with local distribution networks in developing countries also provide an attractive avenue for leveraging unmet demand.

Key Features of the Study:

• This report provides in-depth analysis of the global telmisartan market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global telmisartan market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include, Boehringer Ingelheim GmbH, Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Abbott Laboratories, Cadila Healthcare Ltd, Torrent Pharmaceuticals Ltd., Merck KGaA, Pfizer Inc., Sanofi S.A., Bayer AG, AstraZeneca PLC, Daiichi Sankyo Company, Limited, Macleods Pharmaceuticals Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global telmisartan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global telmisartan market

Detailed Segmentation-

• By Composition
  • Single
  • Combinational
• By Indication
  • Hypertension
  • Nephropathy
  • Hepatorenal Syndrome
  • Cardiac Arrest
  • Stroke
• By Dosage Form
  • Tablets
  • Capsules
  • Injection
  • Oral suspension
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Boehringer Ingelheim GmbH
  • Glenmark Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Cipla Ltd.
  • Abbott Laboratories
  • Cadila Healthcare Ltd
  • Torrent Pharmaceuticals Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • AstraZeneca PLC
  • Daiichi Sankyo Company, Limited
  • Macleods Pharmaceuticals Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Composition
  • Market Snapshot, By Indication
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Telmisartan Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Telmisartan Market, By Composition, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Single
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Combinational
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Telmisartan Market, By Indication 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hypertension
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nephropathy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hepatorenal Syndrome
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiac Arrest
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Stroke
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Telmisartan Market, By Dosage Form, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Tablets
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Capsules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral suspension
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Telmisartan Market, By Distribution Channel 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Telmisartan Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Composition, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Boehringer Ingelheim GmbH
    • Company Highlights
    • Composition Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Glenmark Pharmaceuticals Ltd.
    • Company Highlights
    • Composition Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Composition Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sandoz International GmbH
    • Company Highlights
    • Composition Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Aurobindo Pharma
    • Company Highlights
    • Composition Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Composition Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mylan N.V.
  • Cipla Ltd.
  • Abbott Laboratories
  • Cadila Healthcare Ltd
  • Torrent Pharmaceuticals Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • AstraZeneca PLC
  • Daiichi Sankyo Company, Limited
  • Macleods Pharmaceuticals Ltd.

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact